These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 14742906)

  • 21. Cystatin C Shifts APP Processing from Amyloid-β Production towards Non-Amyloidgenic Pathway in Brain Endothelial Cells.
    Wang XF; Liu DX; Liang Y; Xing LL; Zhao WH; Qin XX; Shang DS; Li B; Fang WG; Cao L; Zhao WD; Chen YH
    PLoS One; 2016; 11(8):e0161093. PubMed ID: 27532339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
    Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
    J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective nicotinic receptor consequences in APP(SWE) transgenic mice.
    Bednar I; Paterson D; Marutle A; Pham TM; Svedberg M; Hellström-Lindahl E; Mousavi M; Court J; Morris C; Perry E; Mohammed A; Zhang X; Nordberg A
    Mol Cell Neurosci; 2002 Jun; 20(2):354-65. PubMed ID: 12093166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi.
    Xia W; Zhang J; Ostaszewski BL; Kimberly WT; Seubert P; Koo EH; Shen J; Selkoe DJ
    Biochemistry; 1998 Nov; 37(47):16465-71. PubMed ID: 9843412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease.
    Mueller-Steiner S; Zhou Y; Arai H; Roberson ED; Sun B; Chen J; Wang X; Yu G; Esposito L; Mucke L; Gan L
    Neuron; 2006 Sep; 51(6):703-14. PubMed ID: 16982417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracellular biology of Alzheimer's disease amyloid beta peptide.
    Hartmann T
    Eur Arch Psychiatry Clin Neurosci; 1999; 249(6):291-8. PubMed ID: 10653285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of CD2-associated protein deficiency on amyloid-β in neuroblastoma cells and in an APP transgenic mouse model.
    Liao F; Jiang H; Srivatsan S; Xiao Q; Lefton KB; Yamada K; Mahan TE; Lee JM; Shaw AS; Holtzman DM
    Mol Neurodegener; 2015 Mar; 10():12. PubMed ID: 25887956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reelin delays amyloid-beta fibril formation and rescues cognitive deficits in a model of Alzheimer's disease.
    Pujadas L; Rossi D; Andrés R; Teixeira CM; Serra-Vidal B; Parcerisas A; Maldonado R; Giralt E; Carulla N; Soriano E
    Nat Commun; 2014 Mar; 5():3443. PubMed ID: 24599114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased Abeta secretion by cells expressing familial Alzheimer's disease-linked mutant presenilin 1.
    Shimojo M; Sahara N; Murayama M; Ichinose H; Takashima A
    Neurosci Res; 2007 Mar; 57(3):446-53. PubMed ID: 17210196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced accumulation of tau in doubly transgenic mice expressing mutant betaAPP and presenilin-1.
    Samura E; Shoji M; Kawarabayashi T; Sasaki A; Matsubara E; Murakami T; Wuhua X; Tamura S; Ikeda M; Ishiguro K; Saido TC; Westaway D; St George Hyslop P; Harigaya Y; Abe K
    Brain Res; 2006 Jun; 1094(1):192-9. PubMed ID: 16713590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reducing amyloid plaque burden via ex vivo gene delivery of an Abeta-degrading protease: a novel therapeutic approach to Alzheimer disease.
    Hemming ML; Patterson M; Reske-Nielsen C; Lin L; Isacson O; Selkoe DJ
    PLoS Med; 2007 Aug; 4(8):e262. PubMed ID: 17760499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
    Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M
    Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis.
    Herzig MC; Winkler DT; Burgermeister P; Pfeifer M; Kohler E; Schmidt SD; Danner S; Abramowski D; Stürchler-Pierrat C; Bürki K; van Duinen SG; Maat-Schieman ML; Staufenbiel M; Mathews PM; Jucker M
    Nat Neurosci; 2004 Sep; 7(9):954-60. PubMed ID: 15311281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic administration of R-flurbiprofen attenuates learning impairments in transgenic amyloid precursor protein mice.
    Kukar T; Prescott S; Eriksen JL; Holloway V; Murphy MP; Koo EH; Golde TE; Nicolle MM
    BMC Neurosci; 2007 Jul; 8():54. PubMed ID: 17650315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer's 5xFAD mice.
    Fragkouli A; Tsilibary EC; Tzinia AK
    Neurobiol Dis; 2014 Oct; 70():179-89. PubMed ID: 25008761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor.
    Davis J; Xu F; Deane R; Romanov G; Previti ML; Zeigler K; Zlokovic BV; Van Nostrand WE
    J Biol Chem; 2004 May; 279(19):20296-306. PubMed ID: 14985348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cystatin C. Icelandic-like mutation in an animal model of cerebrovascular beta-amyloidosis.
    Wei LH; Walker LC; Levy E
    Stroke; 1996 Nov; 27(11):2080-5. PubMed ID: 8898820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cystatin C colocalizes with amyloid-beta and coimmunoprecipitates with amyloid-beta precursor protein in sporadic inclusion-body myositis muscles.
    Vattemi G; Engel WK; McFerrin J; Askanas V
    J Neurochem; 2003 Jun; 85(6):1539-46. PubMed ID: 12787072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abeta40 inhibits amyloid deposition in vivo.
    Kim J; Onstead L; Randle S; Price R; Smithson L; Zwizinski C; Dickson DW; Golde T; McGowan E
    J Neurosci; 2007 Jan; 27(3):627-33. PubMed ID: 17234594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abeta conformational change is central to Alzheimer's disease.
    Holtzman DM
    Neurobiol Aging; 2002; 23(6):1085-8. PubMed ID: 12470806
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.